Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume $1.05 +0.04 (+3.96%) As of 11:55 AM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aptevo Therapeutics Short Interest DataAptevo Therapeutics (APVO) has a short interest of 386,500 shares, representing 12.00% of the float (the number of shares available for trading by the public). This marks a 220.48% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 597,495 shares to cover all short positions.Current Short Interest386,500 sharesPrevious Short Interest120,600 sharesChange Vs. Previous Month+220.48%Dollar Volume Sold Short$448,340.00Short Interest Ratio0.2 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares1,459,000 sharesFloat Size3,220,000 sharesShort Percent of Float12.00%Today's Trading Volume148,788 sharesAverage Trading Volume597,495 sharesToday's Volume Vs. Average25% Short Selling Aptevo Therapeutics? Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAPVO Short Interest Over TimeAPVO Days to Cover Over TimeAPVO Percentage of Float Shorted Over Time Remove Ads Aptevo Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025386,500 shares $448,340.00 +220.5%12.0%0.2 $1.16 3/15/2025120,600 shares $290,646.00 +100.7%8.3%1.8 $2.41 2/28/202560,100 shares $229,582.00 +155.7%4.1%0.3 $3.82 2/15/202523,500 shares $78,490.00 -46.2%1.6%0.1 $3.34 1/31/202543,700 shares $191,406.00 +64.9%3.0%0.2 $4.38 1/15/202526,500 shares $120,575.00 +39.5%1.8%0.1 $4.55 12/31/202419,000 shares $81,890.00 -92.1%1.3%0.1 $4.31 12/15/2024241,700 shares $988,553.00 +536.1%16.6%0.8 $4.09 11/30/202438,000 shares $14.57 million -94.8%7.6%0.2 $383.32 11/15/2024734,600 shares $155,000.60 -38.8%N/A0.1 $0.21 Get the Latest News and Ratings for APVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptevo Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/31/20241,200,000 shares $323,880.00 +675.7%N/A0.2 $0.27 10/15/2024154,700 shares $22,416.03 +164.9%N/A0 $0.14 9/30/202458,400 shares $10,500.32 +349.2%N/A0 $0.18 9/15/202413,000 shares $4,613.70 -78.8%N/A0 $0.35 8/31/202461,400 shares $22,104.00 -80.2%N/A0 $0.36 8/15/2024310,700 shares $135,154.50 -54.8%N/A0.1 $0.44 7/31/2024687,500 shares $277,268.75 +2.9%N/A0.1 $0.40 7/15/2024668,300 shares $203,965.16 +91.7%N/A0.1 $0.31 6/30/2024348,700 shares $106,702.20 +1,552.6%N/A0.4 $0.31 6/15/202421,100 shares $16,198.47 -55.8%0.5%0 $0.77 5/31/202447,700 shares $33,991.02 -11.7%1.2%0.1 $0.71 5/15/202454,000 shares $43,632.00 -79.9%1.3%0.1 $0.81 4/30/2024268,200 shares $190,609.74 +84.2%16.8%0.3 $0.71 4/15/2024145,600 shares $114,004.80 +324.5%9.1%0.6 $0.78 3/31/202434,300 shares $160,867.00 +18.7%5.1%0.3 $4.69 3/15/202428,900 shares $156,638.00 +725.7%5.5%0.3 $5.42 2/29/20243,500 shares $26,180.00 -82.1%N/A0 $7.48 2/15/202419,600 shares $3,077.20 +17.4%N/A0.1 $0.16 1/31/202416,700 shares $2,715.42 -78.8%N/A0 $0.16 1/15/202478,900 shares $12,545.10 -61.3%N/A0.2 $0.16 12/31/2023203,900 shares $36,905.90 +253.4%N/A0.3 $0.18 12/15/202357,700 shares $9,924.40 -46.0%N/A0.1 $0.17 11/30/2023106,800 shares $19,971.60 +297.0%N/A0.2 $0.19 11/15/202326,900 shares $4,976.50 -74.2%N/A0.1 $0.19 10/31/2023104,300 shares $29,485.61 -19.3%N/A0.2 $0.28 10/15/2023129,200 shares $41,344.00 +7.4%N/A0.3 $0.32 9/30/2023120,300 shares $39,699.00 +161.5%N/A0.4 $0.33 9/15/202346,000 shares $18,446.00 -46.6%N/A0.1 $0.40 8/31/202386,200 shares $37,928.00 +176.3%N/A0.3 $0.44 8/15/202331,200 shares $11,544.00 -97.8%N/A0.1 $0.37Trump Orders 'National Digital Asset Stockpile' (Ad)‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionSHOW ME THE #1 CRYPTO TO OWN RIGHT NOW 7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04 7/15/202335,300 shares $52,950.00 +13.1%N/A0.2 $1.50 6/30/202331,200 shares $45,552.00 +51.5%N/A0.6 $1.46 6/15/202320,600 shares $32,960.00 -59.7%N/A0.4 $1.60 5/31/202351,100 shares $79,716.00 -28.0%N/A1 $1.56 5/15/202371,000 shares $117,150.00 -47.6%N/A1.3 $1.65 4/30/2023135,500 shares $260,160.00 +47.8%N/A2.4 $1.92 4/15/202391,700 shares $174,230.00 -35.1%N/A1.6 $1.90 3/31/2023141,200 shares $287,342.00 +34.2%N/A2 $2.04 3/15/2023105,200 shares $190,412.00 -30.1%N/A1.2 $1.81 2/28/2023150,400 shares $318,848.00 +118.6%N/A0.2 $2.12 2/15/202368,800 shares $141,040.00 -49.1%N/A0.1 $2.05 1/31/2023135,100 shares $310,730.00 -27.3%N/A0.2 $2.30 1/15/2023185,800 shares $418,050.00 -32.3%N/A0.2 $2.25 12/30/2022274,500 shares $636,840.00 -38.8%N/A0.4 $2.32 12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25 11/30/202251,900 shares $161,928.00 -2.8%N/A1.5 $3.12 11/15/202253,400 shares $178,890.00 -12.3%N/A1.5 $3.35 10/31/202260,900 shares $183,918.00 +6.8%N/A1.3 $3.02 10/15/202257,000 shares $161,310.00 +8.6%N/A0.9 $2.83 9/30/202252,500 shares $159,600.00 +23.8%N/A0.9 $3.04 9/15/202242,400 shares $158,576.00 +3.9%N/A0.7 $3.74 8/31/202240,800 shares $144,432.00 -4.5%N/A0.4 $3.54 8/15/202242,700 shares $195,993.00 -48.9%N/A0.5 $4.59 7/31/202283,500 shares $328,990.00 -9.3%N/A1 $3.94 7/15/202292,100 shares $361,032.00 -30.2%N/A1.3 $3.92 6/30/2022132,000 shares $472,560.00 -24.8%N/A1.4 $3.58 6/15/2022175,600 shares $579,480.00 +20.9%N/A0.8 $3.30 5/31/2022145,200 shares $665,016.00 +1.0%N/A0.7 $4.58 5/15/2022143,700 shares $661,020.00 -13.4%N/A0.7 $4.60 4/30/2022165,900 shares $706,734.00 -12.2%N/A0.7 $4.26 4/15/2022188,900 shares $899,164.00 -6.3%N/A0.7 $4.76 3/31/2022201,600 shares $1.18 million +39.5%N/A0.8 $5.87 3/15/2022144,500 shares $647,360.00 +1.4%N/A1 $4.48 2/28/2022142,500 shares $820,800.00 -19.4%N/A0.6 $5.76 2/15/2022176,800 shares $1.11 million +247.4%N/A0.1 $6.29 1/31/202250,900 shares $297,256.00 -65.8%N/A0 $5.84 1/15/2022148,600 shares $1.07 million -35.3%N/A0 $7.22 12/31/2021229,500 shares $1.81 million -25.8%N/A0.1 $7.87 12/15/2021309,400 shares $2.44 million -72.4%N/A0.1 $7.90 11/30/20211,120,000 shares $11.16 million +1,182.9%N/A0.3 $9.96 11/15/202187,300 shares $848,556.00 +4.9%N/A0 $9.72 10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24 10/15/202162,900 shares $942,871.00 +4.7%N/A1.4 $14.99 9/30/202160,100 shares $927,944.00 -6.1%N/A1.2 $15.44 9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14 8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95 8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00 7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77 7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75Now I look stupid. Real stupid... (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43 6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00 5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12 5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93 4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34 4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57 3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20 3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97 2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62 2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76 1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83 1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82 12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11 12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61 11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39 11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98 10/30/202086,900 shares $572,671.00 +2.4%3.0%0.1 $6.59 10/15/202084,900 shares $594,300.00 -15.1%3.0%1.6 $7.00 9/30/2020100,000 shares $760,000.00 +33.7%3.5%1.2 $7.60 9/15/202074,800 shares $596,156.00 +9.2%2.6%0.1 $7.97 8/31/202068,500 shares $537,040.00 -20.3%2.4%0.1 $7.84 8/14/202085,900 shares $684,623.00 +39.7%3.0%0.1 $7.97 7/31/202061,500 shares $516,600.00 +27.6%2.1%0.1 $8.40 7/15/202048,200 shares $352,342.00 -75.1%1.7%0.1 $7.31 6/30/2020193,600 shares $1.62 million +147.6%6.7%0.3 $8.35 6/15/202078,200 shares $420,716.00 -0.4%2.7%0.8 $5.38 5/29/202078,500 shares $466,290.00 -3.8%2.7%0.6 $5.94 5/15/202081,600 shares $446,352.00 +54.0%2.8%0.6 $5.47 4/30/202053,000 shares $265,000.00 -8.5%1.8%0.4 $5.00 4/15/202057,900 shares $242,022.00 +2.1%2.0%0.7 $4.18 APVO Short Interest - Frequently Asked Questions What is Aptevo Therapeutics' current short interest? Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 386,500 shares of APVO short. 12.00% of Aptevo Therapeutics' shares are currently sold short. Learn More on Aptevo Therapeutics' current short interest. Which institutional investors are shorting Aptevo Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Aptevo Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.00% of Aptevo Therapeutics' floating shares are currently sold short. Is Aptevo Therapeutics' short interest increasing or decreasing? Aptevo Therapeutics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 386,500 shares, an increase of 220.5% from the previous total of 120,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Aptevo Therapeutics' float size? Aptevo Therapeutics currently has issued a total of 1,459,000 shares. Some of Aptevo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptevo Therapeutics currently has a public float of 3,220,000 shares. How does Aptevo Therapeutics' short interest compare to its competitors? 12.00% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aptevo Therapeutics: Carisma Therapeutics, Inc. (2.32%), PharmaCyte Biotech, Inc. (0.44%), Kiora Pharmaceuticals, Inc. (1.95%), Ainos, Inc. (9.15%), Sensei Biotherapeutics, Inc. (0.73%), Addex Therapeutics Ltd (0.44%), Brainstorm Cell Therapeutics Inc. (2.71%), Acurx Pharmaceuticals, Inc. (2.45%), Traws Pharma, Inc. (2.08%), Omega Therapeutics, Inc. (26.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Capital One Financial Co. ($3.79 billion), AppLovin Co. ($2.91 billion), Corcept Therapeutics Incorporated ($1.89 billion), Amcor plc ($1.60 billion), Carnival Co. & plc ($1.16 billion), BCE Inc. ($1.14 billion), AST SpaceMobile, Inc. ($1.10 billion), and Best Buy Co., Inc. ($1.03 billion). View all of the most shorted stocks. What does it mean to sell short Aptevo Therapeutics stock? Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Aptevo Therapeutics? A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further. How often is Aptevo Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies CARM Short Interest Data PMCB Short Interest Data KPRX Short Interest Data AIMD Short Interest Data SNSE Short Interest Data ADXN Short Interest Data BCLI Short Interest Data ACXP Short Interest Data TRAW Short Interest Data OMGA Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:APVO) was last updated on 4/14/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredThe biggest story CNBC isn't talking about (yet)This Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | SponsoredTrump’s betrayal exposed Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredVolatility's Next Big Opportunity?With tariffs rattling the markets, many investors are watching helplessly… But according to legendary "Mark...Brownstone Research | SponsoredTrump 2028 could be a “bonanza” for investorsAs you may have heard, Donald Trump is planning to run for a THIRD term in 2028. Recently he told NBC news ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptevo Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptevo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
